Related Articles
Novel treatment strategies for patients with HER2‑positive breast cancer who do not benefit from current targeted therapy drugs (Review)
Mechanisms of the CDK4/6 inhibitor palbociclib (PD 0332991) and its future application in cancer treatment (Review)
Molecularly targeted therapy and immunotherapy for hormone receptor‑positive/human epidermal growth factor receptor 2‑negative advanced breast cancer (Review)
HER2<sup>+</sup> advanced gastric cancer: Current state and opportunities (Review)
Unraveling trastuzumab and lapatinib inefficiency in gastric cancer: Future steps (Review)